Pot stocks working high—Here is how it be affecting these ETFs
CNBC’s Frank Holland breaks down how cannabis stocks are impacting ETFs. For find real of entry to to are living and distinctive video from CNBC subscribe to CNBC PRO: This…
Inexperienced Thumb CEO on cannabis enhance: Particular person ask is excessive
CNBC’s “Bid on the Avenue” crew discusses pot stock ETFs and sector enhance with Inexperienced Thumb Industries CEO Ben Kovler. For entry to are residing and new video from CNBC…
Reddit rally slack pot stocks: Curaleaf’s Boris Jordan
CNBC’s “Yelp on the Road” personnel discusses how retail merchants keyed in on pot stocks with cannabis firm Curaleaf govt chairman Boris Jordan. For accumulate admission to to live and…
Curaleaf chairman on the realm expansion of hashish availability
Curaleaf executive chairman Boris Jordan joins “Grunt on the Avenue” to discuss regarding the corporate’s expansion into Europe. For win admission to to dwell and extraordinary video from CNBC subscribe…
‘The Father or mother Firm’ board member on its important traders in cannabis
CNBC’s “Recount on the Facet toll road” team discusses the outlook for pot shares and the finest pot SPAC ever with ancient Yahoo CEO Carol Bartz. She’s now a board…
Jim Cramer on investing within the cannabis and playing sectors
CNBC’s Jim Cramer and David Faber stamp up on the cannabis and playing sectors.
ETF Spotlight: Aurora cannabis hit by pandemic-connected restrictions
CNBC’s Morgan Brennan takes a possess a look at cannabis-focused ETFs and the dip in Aurora shares.
‘The Mother or father Firm’ board member on its necessary merchants in cannabis
CNBC’s “Express on the Avenue” workforce discusses the outlook for pot shares and the primary pot SPAC ever with worn Yahoo CEO Carol Bartz. She’s now a board member of…
Pot stocks head greater in wager on U.S. legalization
CNBC’s Frank Holland experiences on the provides being struck within the cannabis dwelling as companies space for attainable legalization within the United States. For procure entry to to stay and…
Jim Cramer on cannabis firms Aphria and Tilray merging
Hashish firms Aphria and Tilray will merge to get the very best global cannabis firm. CNBC’s Jim Cramer and David Faber discuss. Subscribe to CNBC PRO for get entry to…